Business

Amgen Awards The Bath Institute of Rheumatic Diseases $25,000 Through UPLIFT Innovation Challenge

Grant to Support New Digital Programs to Reconnect Psoriatic Arthritis Patients with Healthcare Providers THOUSAND OAKS, Calif., Nov. 17, 2021 /PRNewswire/ --

articleAmgen Inc.November 17, 20213/company/amgen-inc/news/amgen-awards-the-bath-institute-of-rheumatic-diseases-dollar25000-through-uplift-innovation-challenge
Amgen Awards The Bath Institute of Rheumatic Diseases $25,000 Through UPLIFT Innovation Challenge

About this update from Amgen Inc.

[{"type":"text","content":"Grant to Support New Digital Programs to Reconnect Psoriatic Arthritis Patients with Healthcare Providers\n\n\nTHOUSAND OAKS, Calif., Nov. 17, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the awarding of a one-time $25,000 grant to the Bath Institute of Rheumatic Diseases (BIRD) as part of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Innovation Challenge. In partnership with the International Federation of Psoriasis Associations (IFPA), the UPLIFT Innovation Challenge aims to make an impact within the psoriatic disease community by fostering the development of actionable solutions to address a challenge that people living with psoriatic disease and healthcare providers continue to face.\nBIRD was selected from 22 innovative applications by a global, multi-disciplinary judging panel, including patient and advocacy representatives and leading medical experts in psoriatic disease. The $25,000 grant will be used to bring their solution to the psoriatic disease community.\nBIRD's solution proposes to connect people living with psoriatic arthritis and their families with healthcare providers on digital platforms, including a new webinar series and social media advertising campaign. The virtual activities will provide patients an opportunity to have meaningful interactions with healthcare providers to help deepen their understanding of their disease, improve overall wellbeing and overcome existing communication barriers. \nIn recognition of the impact and innovation of their proposed solutions, Amgen selected four additional organizations to each receive honorable mentions and a one-time $20,000 grant, including: \nEpidermia, Panhellenic Association of Patients with Psoriasis and Psoriatic Arthritis Global Healthy Living Foundation Psoriasis Association of Taiwan Psoriasis Philippines Online Community, Inc.\"Amgen is proud to support the UPLIFT Innovation Challenge and the global patient advocacy community, who work every day to address the challenges of those living with psoriatic disease. Together with our expert panel of judges, we were impressed by both the volume and thoughtfulness of applications received from patient organizations around the world,\" said Darryl Sleep, M.D., senior vice president, Global Medical, and chief medical officer at Amgen. \"We congratulate the Bath Institut...

More updates from Amgen Inc.